First Large Case Series Regarding Stem Cell Reimplant Complications Published
We’re proud at Regenexx to announce the world’s first publication of a large, several year case series of patients treated with autologous mesenchymal stem cells and tracked prospectively for complications. The fact that no serious stem cell related complications were reported and the fact that the world’s highest definition MRI technology (3.0 Tesla imaging) was used to track more than 50 re-implant sites over time for tumor formation, makes this paper the first of it’s kind. No other clinic around the globe or even pharma sponsored group has published on anywhere near this number of cases followed for anywhere near this length of time. The upshot, cultured adult stem cells delivered through a needle for orthopedic applications in this large study were safer than the higher risk surgical procedures they helped many patients avoid.
Request a Regenexx AppointmentThis blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.
By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.